Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.46 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8961710 | 0.94 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL8961760 | 0.92 | LTA4H (0.44) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL29134152 | 0.92 | LTA4H (0.44) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL706868 | 0.90 | KCNA3 (0.41) | LTA4HDRD2DRD3KCNH2KCNA3 | |
| SCHEMBL703963 | 0.90 | KCNA3 (0.41) | LTA4HDRD2DRD3KCNH2KCNA3 | |
| SCHEMBL27864101 | 0.88 | LTA4H (0.39) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL707221 | 0.85 | CA4 (0.42) | LTA4HKCNH2KCNA3ALDH1A1LMNA | |
| SCHEMBL1608982 | 0.84 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL703549 | 0.84 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL3913247 | 0.82 | KCNA3 (0.35) | LTA4HKCNH2KCNA3SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10851245-B2 | Polymeric material comprising modified lignin | REN COM AB | 2020-12-01 | — | — | US | disclosed |
| US-10676688-B2 | Composition comprising derivatized lignin for fuel production | REN FUEL K2B AB (SE) | 2020-06-09 | — | — | US | disclosed |
| US-20190233648-A1 | POLYMERIC MATERIAL COMPRISING MODIFIED LIGNIN | LIGNIN INDUSTRIES AB (SE) | 2019-08-01 | — | — | US | disclosed |
| US-20180142177-A1 | COMPOSITION COMPRISING DERIVATIZED LIGNIN FOR FUEL PRODUCTION | REN FUEL K2B AB (SE) | 2018-05-24 | — | — | US | disclosed |
| EP-1326829-A2 | 17-BETA-HYDROXYSTEROID DEHYDROGENASE-II INHIBITORS | Bayer Pharmaceuticals Corporation (US) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002026706-A2 | 17-BETA-HYDROXYSTEROID DEHYDROGENASE-II INHIBITORS | BAYER PHARMACEUTICALS CORPORATION (US) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180142177-A1 | COMPOSITION COMPRISING DERIVATIZED LIGNIN FOR FUEL PRODUCTION | NOX4, DCXR, COXFA4 | LTA4H 22/4885MLNR 4704/4885NR1I2 3698/4885 |
| US-10676688-B2 | Composition comprising derivatized lignin for fuel production | NOX4, DCXR, COXFA4 | LTA4H 22/4885MLNR 4704/4885NR1I2 3698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.